Latest / Lifestyle Design with Freedude / The Truth About Stem Cells: What Regenerative Medicine Can (and Can't) Actually Do
Transcript
- 0:00There's a new subclass of stem cells that are out there called MUSE cells, spelled M-U-S-E. Now, if you were to take, for example, cord blood from a life-healthy birth, you would maybe get 3% to 5% of the cells in that cord blood could be stem cells.
- 0:19MUSE cells only make up about 1% to 3%.
- 0:23If you remove the inflammatory components from injured tissue,
- 0:27whether it's an acute injury or an injury you've had for a long period of time.
- 0:31If you remove those inflammatory components and it starts to balance the immune system, it enables the body to do what it's actually meant to do, which is heal itself.
- 0:43If I'm no longer in pain because it worked, do I care what the x-ray looks like?
- 0:50The first thing we learned in radiology was
- 0:58So let's start stupidly simple.
- 1:01So when people hear regenerative medicine, they imagine Wolverine growing a new knee.
- 1:08What can we actually regenerate today?
- 1:12Well, I've been around this space for a little over 15 years.
- 1:17It actually took me out of clinical practice because of regenerative medicine.
- 1:22And when you think about growing a new knee or growing a new joint, it's what they kind of thought.
- 1:27It was a perception, but it's really not the truth.
- 1:30If you look at it at the molecular level, principally, you are removing the products and the things that are causing your body not to heal.
- 1:42As a simple explanation, if you remove the inflammatory components from injured tissue
- 1:48whether it's an acute injury or an injury you've had for a long period of time, if you remove those inflammatory components and it starts to balance the immune system, it enables the body to do what it's actually meant to do, which is heal itself.
- 2:06Now, what makes it very special in the different...
- 2:10Regenerative medicine components is that when you can add other things that can help to stimulate that tissue to actually heal itself, you're really not creating new tissue.
- 2:24You're sending a signal, and the signal to that cell is to do what you naturally do.
- 2:32But maybe you can amplify that signal because you're no longer able.
- 2:3625, 35, 45 years old, maybe you're in your 60s and that signal has gone a little bit weak.
- 2:44So amplification of the signals that naturally occur in our body is really what it's about.
- 2:51And can you share a little bit more about who you are and what you've been doing during the last 20 years?
- 2:57Sure.
- 2:57So I started my medical career in 1985, which makes me a little bit old.
- 3:03I was a physician's assistant in orthopedic surgery.
- 3:06I went on to medical school and trained as a foot and ankle surgeon.
- 3:11So for 18 years, I worked almost exclusively in foot and ankle surgery.
- 3:17And by the early 2000s, we had started utilizing regenerative medicine.
- 3:23We were utilizing amniotic membrane, wrapping it around tendons and ligaments for repair, and the repair process was happening phenomenally fast.
- 3:33At that time, we had amniotic fluid, which was a great anti-inflammatory component.
- 3:38If you think about where it comes from, the uterus, what that baby is floating in that entire time, all it is is a protectant.
- 3:48It's protecting that baby from everything that's coming at it.
- 3:52So it worked beautifully for speeding up the process of healing.
- 3:59When I, it eventually worked me out of clinical practice and I started working with the laboratories because in the early 2000s, when stem cells started to become talked about, I realized that
- 4:14We didn't use the term regenerative medicine, but that's where this was going.
- 4:19It was my thought that that's where medicine is going.
- 4:23People want to be able to help themselves versus go in and if you look at the subset of population, not everybody who has a bad knee when they go into the orthopedic surgeon's office wants a knee replacement.
- 4:38You have a certain percentage that just say, no, that's not what I want.
- 4:42What is your alternative?
- 4:44And the way we used to talk to physician groups was, don't let that patient go.
- 4:48Right?
- 4:50If you're just letting 20% of your patient population walk out of your office because you don't have what's available for them, that's not a good business model either.
- 5:00And then we started educating on regenerative medicine.
- 5:03The last...
- 5:0515 or so years, that's all I've done, is educate physicians, clinics, medical conferences, now primarily around the world, on all the different facets of regenerative medicine.
- 5:20What is a common misunderstanding about stem cells today?
- 5:26That the stem cell...
- 5:28goes into your body, goes to the site of injury, and grafts into your body and becomes that cell.
- 5:38And that's a complete misconception.
- 5:42However, 15, 20 years ago, that's kind of what we thought because the technology was not there to show us.
- 5:50That's what I thought from all the TikTok videos talking about stem cells.
- 5:55What actually happens is,
- 5:57is that stem cell is attracted to inflammatory components.
- 6:02It's attracted to damaged tissue because in our body, when a cell, whether it's healthy or it's unhealthy, it's putting out signals all the time.
- 6:13And a stem cell itself, whether it's from inside our body, which we have, or it's put into our body, recognizes those homing signals.
- 6:24what happens is that stem cell goes to the site of injury.
- 6:28It directly communicates with that injured cell because the injured cell is giving off the communication and it's telling the stem cell, the nucleus, or the brain inside that stem cell, what they need.
- 6:43That nucleus then directs the organelle within that cell to create those components and,
- 6:51And it puts them in these little packets inside the cell called endosomes.
- 6:56It's an endosome because it's inside.
- 6:59It then expels that packet outside of the cell where it becomes an exosome.
- 7:06because it's exited the cell.
- 7:08The scientific term is actually secretome because it secretes out, but the word exosome has picked up.
- 7:16It's the exosome that goes to the site of the damaged cell, interacts, releases its messenger RNA, and begins the process of getting the components that are necessary for that damaged cell actually to potentially repair itself.
- 7:39And so stem cells, PRP, peptides, exosomes, BMA say, so what's actually different?
- 7:48I hope you have some time.
- 7:51We have some time.
- 7:53So stem cells essentially are the carriers of the exosomes.
- 7:59They go to the site.
- 8:01That's why it's so exciting.
- 8:03I spoke about at the conference in Cancun is the history and the future of exosomes.
- 8:10Because when you inject a cell into your body that comes from another individual, you always have a chance for what's called an antigenic response or a mild allergic response.
- 8:29which is the exosome or secretome, you now no longer have cellular components.
- 8:37All you have is secretion and your potential for that allergic or antigenic response is essentially gone.
- 8:44So instead of using the carrier, just use the endoproduct, put that at the site of injury and let it happen on its own.
- 8:54Now, there are
- 8:55Positives to both, definitely.
- 8:58I think there are some times when the stem cell could be more beneficial than putting in the direct exosome.
- 9:05But you kind of have to evaluate that on a case-by-case basis.
- 9:09Now, PRP itself, I mean, I'm 66 years old, okay?
- 9:15You look great.
- 9:17Well, thank you.
- 9:17If you want to draw my blood and pull out my platelet-rich plasma...
- 9:23and put it into my body, it's probably going to have somewhat of a positive effect.
- 9:29But the PRP is only as good as the patient it's coming from.
- 9:35So if you have an obese, diabetic,
- 9:42with hypertension that comes into your office because they're having knee, shoulder, hip problems, and you pull that PRP, that's the grade of PRP that you're going to get based on the health of that patient.
- 9:56So is it bad?
- 9:58No.
- 9:58No.
- 9:59There's going to be some positive to it, but there are grades of positive.
- 10:04Look at a stem cell that secretes exosome.
- 10:06That stem cell is one day old.
- 10:10How potent do you think that one-day product is versus even 35, 45, 55, 65-year-old patient?
- 10:20It's significantly different.
- 10:22So stem cells, exosomes, bone marrow aspirate, again, is only as good as the health of the patient that it came from.
- 10:33So I like...
- 10:36The stem cell and the exosome derived in most cases, but I can tell you, I've gotten calls from doctors that have said, I got a 21-year-old in here with a partial ACL tear.
- 10:47Which stem cell do you think I should use?
- 10:49I said, no, you should use his stem cells.
- 10:53That 21-year-old has got powerful stem cells in their body.
- 10:5861-year-old, we would have a different discussion about what avenue to potentially walk down.
- 11:05So share broadly, where do stem cells come from?
- 11:10So what you said here, it sounds like I thought just stem cells were just stem cells, and it's just like one type of stem cells, and everybody can benefit from it.
- 11:25So that's not true.
- 11:27No.
- 11:27So when we're born, one out of every 10,000 cells in our body is a stem cell.
- 11:33By the time we reach skeletal maturity, what that's a girl, maybe 13, 14, maybe 16 to 18-year-old on a boy, that count is already down to one out of 100,000.
- 11:46By the time you reach the age of 60, it's like down to one in two million.
- 11:52By the time you reach the age of 80, it's like one in four million.
- 11:56So if you do a bone marrow aspirate
- 12:00On me, in my 60s, I'm going to have nowhere near the count of stem cells in my body as even a 50-year-old or a 40-year-old or a 30-year-old.
- 12:12So they come from multiple areas.
- 12:14When we utilize the stem cells from a live, healthy birth, which to be very clear, specifically in the United States, and I'm pretty sure most places in Europe, aborted fetuses are not allowed to be used.
- 12:29But has it been so before?
- 12:33Was it allowed before?
- 12:36Before 1988, there was a ruling by George H.W.
- 12:40Bush that said no.
- 12:42But they weren't utilizing them in humans.
- 12:44They were utilizing them for research.
- 12:47So it wasn't as if they did stem cell transfers.
- 12:50They were just doing research with them.
- 12:52They didn't want to waste something that's already being, so to speak, wasted.
- 12:58Yeah, exactly.
- 13:00So in a live, healthy birth, the second that baby comes out of the body, it's considered an adult stem cell.
- 13:11If it's taken from inside of the body, it's considered a fetal stem cell.
- 13:16So that passage out the birth canal makes it an adult stem cell.
- 13:21Now, from there, you can utilize the core blood.
- 13:25which has a certain concentration of stem cells.
- 13:28You can utilize actually the internal lining of the umbilical cord, which we call cord tissue.
- 13:36There's a concentration of stem cells.
- 13:38Or you can actually use what they call the Wharton's jelly, which is the thickened gelatinous-type component inside the cord that keeps it from kinking.
- 13:51Right?
- 13:51It gives us that strength.
- 13:53All those three areas do have stem cells.
- 13:56Now, there's a raging debate on whether or not there are any stem cells in the actual amniotic fluid.
- 14:04Most of science says...
- 14:07Probably not.
- 14:08There may be a little bit, but probably not.
- 14:10Mostly that's just full of excellent anti-inflammatories and growth factors that are really a protectant to the fetus.
- 14:18Now, also in the adult, you can get it from their bone marrow aspirin.
- 14:24Some people will tell you you can get it from peripheral blood, but it's going to be very low anywhere you get it.
- 14:30You have stem cells in the pulp of your teeth.
- 14:33But it'd be kind of rough to yank a tooth just to get some stem cell.
- 14:37And it could be a little specific, right?
- 14:41And there are stem cells in plants, right?
- 14:45And that's a raging debate that we see also because—
- 14:50It's really not a debate because one of the things that we teach is source is by far the most important factor.
- 14:58What carries that source of that stem cell, whether it's human or it's plant, determines what the cargo is going to be inside that stem cell.
- 15:11So if I take a human stem cell and we utilize the exosomes, or actually just use the stem cell,
- 15:17I'm going to have the effects of that stem cell.
- 15:20Now, they're called MSCs or mesenchymal stem cells because it's specific to a type of tissue in the body, a stromal tissue that it works from.
- 15:31But if you consider putting a human product into a human versus putting a plant product into a human, I don't think you have to be a rocket scientist to figure out one may actually give you significantly more benefits than the other.
- 15:48I can't say it's worthless because there's going to be some components in there that could help stimulate your body in different ways.
- 15:55And we see it a lot with topical cosmetics.
- 16:00I know products that list they have stem cells or they have exosomes.
- 16:05And then when you read in the ingredients, it comes from like a vanilla bean.
- 16:11So I wonder what's the vanilla bean going to do for me?
- 16:15Yeah.
- 16:16Does it do anything or is it just marketing?
- 16:19Well, you might get a little bit of inflammatory response.
- 16:22There are some growth factors in there that have some crossover and could help a little bit, but not to the same benefit that you're going to get from something that comes from your own species.
- 16:35So what's something regenerative medicine clinics are selling right now where you think, guys, we do not have enough evidence for this yet?
- 16:47Well, there's many, many clinical trials going on in the U.S. with stem cells.
- 16:53Exosomes are a little behind that curve just because of the technology gap.
- 17:00There's a lot being used for orthopedics.
- 17:02That is probably the leading area that's going on for research.
- 17:08Neurology is slower because many research institutes have found out that your basic stem cell
- 17:17lacks the capability to regrow neural tissue.
- 17:22So a spinal injury, you would think we could get those stem cells in there right away and we could, they've not found that to be the case.
- 17:28I have a very good friend here in the United States that researched it for many years and finally just stepped away to work on more regeneration because it wasn't going there.
- 17:38But that being said, there's a new subclass of
- 17:43stem cells that are out there called muse cells spelled m-u-s-e muse cells yeah dr marie dozawa of japan was the first one to discover it many many years ago and it's a sub population within the actual msc the mesenchymal stem cell now if you were to take for example cord blood from a life healthy birth
- 18:12You would maybe get 3% to 5% of the cells in that cord blood could be stem cells.
- 18:21How much, again, can you say that again?
- 18:23Approximately 3% to 5% of all of the cells in that cord blood could be stem cells.
- 18:30Yeah.
- 18:30Now, mu cells only make up about 1% to 3% of that 3% to 5%.
- 18:38So there were very, very small subpopulation in there.
- 18:42The difference is a regular stem cell is what's called multipotent.
- 18:48It can affect adipose tissue.
- 18:50It can affect bone.
- 18:51It can affect cartilage.
- 18:54A muse cell is what's called pluripotent.
- 18:58Meaning they don't know any tissue that it can't have an effect on.
- 19:05But that should give you two things to think about.
- 19:08That's very exciting, but in a way it's a little scary.
- 19:13Why is it scary?
- 19:16Now, the claim so far is that it's non-tumorgenic.
- 19:20that it doesn't stimulate the focus of tumors.
- 19:24But if they don't yet know all the tissues it can have an effect on, that can still be a little bit of a scary thought, and I think people need to look into that.
- 19:36But the reason that Muse even came to mind was because it could very well be the breakthrough in neurology for spinal cord injury.
- 19:45and that sort of thing.
- 19:46Because we know regular stem cells and cardiology, fantastic.
- 19:50Wound care, fantastic.
- 19:53Some neurodegenerative, the problem with the neurodegenerative processes like a Parkinson's or an Alzheimer's is they're all progressive diseases.
- 20:04And if grandma comes and has an infusion of stem cells and she gets better,
- 20:11You would have to continue those infusions for her entire lifespan to potentially make her life better.
- 20:19They haven't figured out how to reverse it.
- 20:20They haven't figured out how to get rid of it.
- 20:23So there's a lot of limitations that people need to think about when it comes to regenerative medicine.
- 20:29And there are limitations.
- 20:33I was thinking about a specific, if we could go in and treat a specific case, and I don't have no idea how we would go about this, but it's just as a thought experiment here, because I have you on.
- 20:48What can regenerative medicine realistically do for varicose veins today?
- 20:56Because this summer I just got diagnosed with varicose veins, level C3, and I'm 42.
- 21:05I'm not supposed to have this shit.
- 21:06But they told me it's 100%.
- 21:11What do you say?
- 21:13What's the word I'm looking for?
- 21:15You inherited it from your parents.
- 21:19Yeah, it's genetic.
- 21:20Thank you for that.
- 21:21So can we actually repair damaged venous valves or are current treatments still mostly about closing or removing dysfunctional veins?
- 21:30Because they wanted to operate me as you were speaking about the knee operation before.
- 21:35And I want to know what options do I have?
- 21:39Is it that or doing knee or a cough raises?
- 21:44Regen is probably not going to do a lot for you.
- 21:48Yeah.
- 21:49You have a mechanical problem, essentially, that the valves in your venous outflow are a little bad.
- 21:56I mean, there are...
- 21:58Options to try before you get to the vein stripping category.
- 22:05Sometimes they'll reverse, you know, take an artery and put it in the place of a vein and reverse it so that the valves are going in the right direction and that sort of thing.
- 22:14But typically their biggest response is we'll just strip the vein out of there because veins can, you know, they're all over the place.
- 22:22You can get that blood flow.
- 22:24But there are some simple things can be done.
- 22:26I mean, compression socks and that sort of thing in order to give that tension to that vein.
- 22:32The tension has been relaxed because when the valve is blown, all the pressure keeps going downhill.
- 22:37So if you can give some compression tension to that, it could help the blood flow.
- 22:43But no, Regen medicine, to my knowledge, isn't really there.
- 22:49I love how you answered that question because sometimes we get people on the show and they found a cure and it's the cure for everything.
- 23:00We've got to be realistic.
- 23:01It will fix your car.
- 23:02We've got to be realistic.
- 23:04So what treatment gets dismissed as experimental or woo-woo today that you think may look back on in 20 years and realize was ahead of its time?
- 23:19Well, there are really multiples.
- 23:23Specifically, orthopedics, we know, works very, very well.
- 23:28Not everybody's exactly the same.
- 23:29It takes different time.
- 23:31We know cardiology has had tremendous response due to it.
- 23:36We know that during the whole COVID thing,
- 23:39that if people utilize stem cells or exosomes, they had rapid recovery and many times did not have the significant side effects.
- 23:50Autism is showing tremendous moves with exosomes.
- 23:56When you come to the realization that the cell in the stem cell is not doing the work, it's just releasing the exosomes, and that's why we saw
- 24:09Autistic children get better with IV infusions.
- 24:13But we said, but hold on, there's a blood-brain barrier around your brain that doesn't allow large molecules to get in.
- 24:21And primarily that's to protect you from bacteria.
- 24:25But they saw physiological changes in these autistic children.
- 24:31How could you explain that?
- 24:33Well, the way they explained it eventually with the advent of technology was because it was the release of the exosomes.
- 24:41And the exosomes are nanometers in size, 30 to 150 nanometers.
- 24:48I mean, there's a million nanometers in a millimeter.
- 24:51So, I mean, you know, these things are tiny.
- 24:54So they were getting across a barrier.
- 24:56So I think that what they're seeing with the technology associated with autism.
- 25:02in exosomes is fantastic.
- 25:05And I think that the breakthrough of Muse with neurology has great, great potential.
- 25:13I think that has a lot of potential.
- 25:17And part of what I talked about in this conference this week was where we've been.
- 25:24We know where we've been, where we're at today, but kind of what you brought up, what's the potential for the future?
- 25:32Right?
- 25:32Because where are we going to be?
- 25:35Well, with the advent of AI, I think it's significant.
- 25:40I mean, we have to understand AI can only give us information that's already known.
- 25:46However, an example I use is a great scientist over the course of his life may be able to evaluate, say, a few hundred data sets for their theories.
- 26:00Yet AI could evaluate a million before launch.
- 26:05Now, it's known data, but it's working through those data sets that you've got to do in order to find out whether or not your theory has legs.
- 26:14So if you could use that computational power for that mundane work that takes so much time, 90% of their time is figuring out the data sets.
- 26:27And this is where I think the future has potential.
- 26:31Then in working with AI, you could potentially test so many more theories so much more rapidly and get to those answers.
- 26:43Because the answers that are coming today weren't because they had the idea yesterday.
- 26:49because they had the idea many years ago, and they've worked through these tons of data sets.
- 26:54So I think, you know, as part of that answer, not a condition, but I think AI could lead us in the direction of personalized therapies that could be specific for my kidney disease or your vascular disease or whatever it is.
- 27:17So I read the book by Tony Robbins called Life Force.
- 27:22I can't remember the date when it came or what year it came out, but something along the lines that when a scientific breakthrough is made until it comes out to the public,
- 27:36for doing those treatments.
- 27:38It's about around 17 years, right?
- 27:40Am I recalling that correctly?
- 27:44That's probably about right.
- 27:45And what is something that is actually FDA approved today and can do a lot of benefits for humanity that most people and most physicians don't know about?
- 28:00Well, so FDA approved kind of puts a little cramp on it.
- 28:05Okay, forget FDA approved.
- 28:08Because that limits it a little bit.
- 28:10But take, for example, Dr. Arnold Kaplan identified and named the mesenchymal stem cell in 1987.
- 28:18We didn't see it in the marketplace until 2008, 2010.
- 28:23Wow.
- 28:25It took that long really to get there.
- 28:28If you look at the GLPs.
- 28:30They didn't just happen.
- 28:32It wasn't just yesterday, the GLP-1s that came around.
- 28:35I mean, they were identified like in 2004.
- 28:41You know, and that's another great conversation of peptides.
- 28:45You know, I think Ozempic or the first GLP-1
- 28:49The investigational work towards approval was like in 2004.
- 28:53So it's a long way back.
- 28:56And people think that peptides are brand new, a brand new phenomenon, right?
- 29:00Well, what's the first peptide that we all know about?
- 29:04Is it insulin?
- 29:05Yeah, yeah.
- 29:06That was in the 1920s, right?
- 29:09Think about it.
- 29:10It's a 50-1.
- 29:11Holy shit, yeah.
- 29:13That's crazy.
- 29:14That's crazy to say 1920s.
- 29:17In the 1920s is when they first started clinical application.
- 29:20So imagine how long before that they did the research.
- 29:24Yeah.
- 29:24And that has saved tens of millions of lives because it used to be if you were born with type 1 diabetes, it was a death sentence.
- 29:32Unless you could live a complete life with your body in ketosis.
- 29:37And then it wasn't a guarantee.
- 29:39You might die anyway.
- 29:41But think about the complexity.
- 29:43That's a 51 amino acid peptide.
- 29:48I think there was a lot of guess and hope and luck that went on to bring that out because the technology was not there to identify it.
- 29:56They didn't know until many years later how many peptides were associated with insulin.
- 30:04So let's go into peptides.
- 30:06What do we need to know about peptides?
- 30:09Well, number one, they're not new.
- 30:11Right?
- 30:11They're not what?
- 30:12They're not new.
- 30:14They're not new.
- 30:15They're not brand new.
- 30:17It's just, you know, with insulin.
- 30:19And we know the case and the history of insulin.
- 30:21But you look at the GLP-1s, Ozempic, Wigovi, Manjuro, Zepbound,
- 30:30They're all the ones that brought it up and finally brought recognition due to social media.
- 30:36Right.
- 30:37They were they've been around for quite some time.
- 30:40But once they got the recognition and then people started asking, especially on social media, well, if they can do that for my body and they can do that for metabolism, how about.
- 30:54My hormones?
- 30:55How about my HGH levels?
- 30:57How about all those other variables in our body?
- 31:01And it really got science moving forward that it was already produced and out there and the science work was done.
- 31:11They just finally saw a market for it and they were able to release it to the marketplace.
- 31:16Can we just like step back a little bit and dig into like what is actually a peptide and what does it do in the body?
- 31:24Like the basics.
- 31:25Right.
- 31:26So peptides are short chain amino acids.
- 31:30Right.
- 31:31typically going to be less than 20 amino acids.
- 31:35So what's an amino acid?
- 31:37A protein is made of typically 100 up to 40,000 amino acids that are attached together.
- 31:47So when we eat food and we consume, we have to consume amino acids, specifically seven essential amino acids,
- 31:56in order for our body to put them together and create proteins.
- 32:01Well, peptides are just shorter versions of that.
- 32:05And the peptides themselves primarily are signaling mechanisms.
- 32:11They signal a cell for a very specific function.
- 32:16If you take Tessamorlin, for example,
- 32:21It specifically signals a cell to stimulate the pituitary gland to release more human growth hormone.
- 32:31Or BPC-157.
- 32:33It goes into your gut, is digested, goes to your brain through the gut-brain axis, and tells a very specific subset of cells in your brain, ignore that inflammation.
- 32:46Don't create inflammation at that site.
- 32:49So proteins have a very massive effect on our body, but the peptides themselves in a similar way, but different is they are very, very specific.
- 33:03GHKCU, for instance, right now, which people are really excited about, specifically tells the fibroblasts, create more collagen.
- 33:15That's it.
- 33:19So this might be a stupid question.
- 33:21So when you get the signal, create more collagen as an example, from what does it create more collagen?
- 33:29It feels like if it's going to create more collagen, it must take something from somewhere inside.
- 33:35And I will get a deficiency somewhere else in order to create this collagen.
- 33:41This is just me thinking here out loud.
- 33:43Sure, sure.
- 33:44Fibroblasts in our body are designed to create collagen.
- 33:49They manufacture it.
- 33:51Based on the nutritional needs of a fibroblast, they manufacture it.
- 33:54It doesn't take it from anywhere else.
- 33:56They are the machinery that makes the collagen in our body.
- 34:01So if there's something that stimulates collagen,
- 34:04that fibroblast, you'll make more collagen.
- 34:07As an example, how genius the body has put together.
- 34:11When collagen gets old, it starts to break up into small pieces.
- 34:16Fibroblasts recognize those small pieces and say, oh my gosh, there must be collagen breakdown.
- 34:24We need to make more collagen.
- 34:27So some curious scientist said,
- 34:31We can give them GHKCU, which stimulates the fibroblasts.
- 34:35What if we make a peptide that looks like a collagen fragment?
- 34:42It's a collagen mimetic, right?
- 34:44It mimics a fragment of collagen.
- 34:48And the fibroblasts go, oh, look at that.
- 34:51There's a fragment.
- 34:52We need to make more collagen.
- 34:54So the line I use,
- 34:57And Dr. Lauren Picard, the man who actually identified GHKCU in 1971, one of the greatest quotes from his book, he says, It's not the smartest scientist who makes the greatest discovery.
- 35:13It's the most curious scientist.
- 35:16He said, and that's typically why the old ones don't make great discoveries, because they get locked into pathways, right?
- 35:22It's these young guys who think outside the box, who've not been forced into this mold.
- 35:27And that's where I think that scientists, it had to be some really curious scientists that said, well, geez, we know what fibroblasts do.
- 35:38Let's make this fragment and see if that works.
- 35:41And it worked.
- 35:42So peptides are pretty crazy.
- 35:45Yeah.
- 35:46And before anybody runs out there and starts shooting up themselves with peptides, what's the correct way to get peptides?
- 35:55And what is some horrific ways that you've seen, heard of, or is it completely like without any issues?
- 36:06I mean, you need to be with a trusted medical professional who's done their research, who understands it.
- 36:12They've also researched the lab that they're getting it from.
- 36:15They need to have certain certifications and GMP and all that sort of thing.
- 36:21Unfortunately, there's a lot of compounding labs that make stuff that they call peptides, but they're not necessarily peptides.
- 36:30And GMP in the United States is called good manufacturing practice.
- 36:35And it's called CGMP.
- 36:37It's not for certified good manufacturing practice.
- 36:41It's for current good manufacturing practice because everything you do every single day either puts you in or out of that category.
- 36:52So for a lab, it's going to be, I think it's a 503B if I can remember right.
- 36:59Labs aren't really my thing.
- 37:00Yeah.
- 37:02You have to have very specific criteria.
- 37:05So your provider needs to know their source, and the patient really needs to know and trust their provider.
- 37:18And is there a list of what's actually legal?
- 37:21So what's approved for medical use and where does it cross into this gray market territory?
- 37:27Because I've been hearing like now friends that are chiropractors like, I'm getting these peptides from China and my wife looks phenomenal, amazing, and I lost all this weight and look at my muscles.
- 37:42Like people are getting bananas about peptides.
- 37:45Yeah.
- 37:46But for me, ordering something from China, I couldn't even get my surfboard company up and running because I had so much issues with getting deliveries in the correct way from China.
- 38:00When it comes to surfboard, I'm not going to get peptides where I don't trust the source, as you were alluding to.
- 38:08Source is important.
- 38:08In the United States, if you want to talk about approved products, the list is very, very short.
- 38:13It's a short list, yeah.
- 38:15Yeah.
- 38:15The GLPs have been approved.
- 38:17The GLP ones.
- 38:19Now, you probably heard the word terzepatide and retitrutide.
- 38:24Now, I think that terzepatide was put on the green list as okay.
- 38:30But retitrutide has not yet been put on that list.
- 38:34But there is a very well-known one, tesamoralin.
- 38:38Tessamorlin is the one that stimulates the precursor to the pituitary gland to make more human growth hormone.
- 38:46It was approved by the FDA about 15 years ago for HIV patients because when you can increase the human growth hormone, that can significantly decrease the fat around your organs or your visceral fat.
- 39:03They didn't want HIV patients necessarily losing body fat or muscle associated with it, but they did want to try to make them healthier with the reduction of visceral fat.
- 39:17Other than that, I think, and I could be wrong, maybe BPC-157, but there just aren't that many that are actually approved in the United States.
- 39:29Yeah.
- 39:33So there's a lot of podcasts coming out right now, and they are talking about so many other peptides that are not approved.
- 39:44That's a majority.
- 39:46That's the majority.
- 39:48And what happens if I take illegal substances?
- 39:54Illegal peptides.
- 39:55Right.
- 39:56So.
- 39:58Not to my body.
- 39:59I mean, like, legally.
- 40:00Right.
- 40:01So the lab, if they're making them inappropriately, the compounding labs in the United States can be held liable for it.
- 40:11A provider, and as far as the FDA is concerned, the FDA does not control the practice of medicine.
- 40:20which is important to know.
- 40:22So if I'm your provider, I can have a very specific discussion with you about how I believe these function and how science has shown how these peptides function.
- 40:35And you say, yeah, that's something I'd like to do.
- 40:38You're going to sign off on it.
- 40:39And it's going to say, I understand this is not FDA approved.
- 40:43And it's going to be some document that some lawyer has made that's incredibly ridiculous.
- 40:47And you're going to sign off on it.
- 40:50In the U.S., where people typically get in trouble is they advertise.
- 40:57I have, you know, BPC-157 will take away your pain.
- 41:02PT-141 will give you an erection or whatever it is along that.
- 41:07They're making claims about treatment protocols.
- 41:13And the only way that you can make a claim is if it is approved as a drug.
- 41:19So you'll even notice if you listen to the Ozempic or the Wigobiat, they're very careful about how they speak.
- 41:26You know, you're going to lose weight.
- 41:28No, this gives you the opportunity to blah, blah, blah.
- 41:31You as a patient don't really have any liability associated with it that I know of, other than the possibility you get something bad.
- 41:42But I can tell you, I just don't hear about people having negative reactions to peptides.
- 41:50And you would think you would at some point in time.
- 41:53I just don't hear much of that.
- 41:57That's why, because I was just thinking about like if I started to take peptides and I will go off it, it will basically have some form of negative effect on me.
- 42:13It's not like say you're taking a, well take the example of Tessa Morlin versus raw HTH, human growth hormone.
- 42:24If I take, inject human growth hormone in my body, which is what my pituitary gland makes, the pituitary gland is eventually going to say, I don't need to make it because look at all that stuff that's out there.
- 42:38However, if you take a tesamoran,
- 42:41which stimulates the precursor to create more HGH.
- 42:46When I go off that test of Morlin, the only thing that's going to happen is I'm going to have less HGH in my body, but it never affects the function of my pituitary gland.
- 42:59So they're, they're, they're signaling mechanisms in the peptides and they're very short acting.
- 43:06Most
- 43:0848 to 72 hours, the function of that peptide, that signal is waning and it's going away.
- 43:16We see that a lot with cosmetic peptides.
- 43:19They have a very short half-life.
- 43:21So we've had to create different products in order to elongate that half-life if possible.
- 43:30Can you share a case where someone is struggling with something with their health?
- 43:39and then they use it for a while, but they are not hooked on it for life.
- 43:45Oh, sure.
- 43:45I think your GLPs are a great example of that.
- 43:49You are moderately maybe obese.
- 43:53I have a niece who is probably more than a hundred pounds overweight, and she finally came to me and said, I wanna try it.
- 44:00So she, and we talked about it and she got on it.
- 44:03And she calls me after the first month, says I'm a little frustrated, I haven't lost that much weight.
- 44:09I said, well, number one, you have to recognize that when you don't have hunger, you have to start changing how you think about food.
- 44:19Just because it's 12 noon doesn't mean you have to go to Taco Bell.
- 44:24Think about how you eat food, why you eat food, and the food you're eating.
- 44:30Because if you can train your brain while you're doing that and you're losing significant amounts of weight, now she's down 60 pounds.
- 44:39And she's doing great, and she's learned to eat properly.
- 44:43When somebody puts you on GLPs, you need to discuss your protein intake that is necessary.
- 44:51You want to take the foods that are necessary in order to give you the nutrition that you need.
- 44:56You're going to be eating a lot less food, so what you eat is very important.
- 45:01And you should, at some point in time, cycle off them.
- 45:05I don't know why anybody would stay on a GLP after they needed to lose weight.
- 45:10Now, I do know that some people will every like three or four months just do one bile just to kind of remind their body of what it feels like.
- 45:21But most of the peptides you should be able to cycle in and out of depending on what you're looking to gain.
- 45:29PT-141, for example, stimulates your brain for sexual arousal.
- 45:36Whereas Viagra itself just opens up the blood flow.
- 45:41So would you take PT-141 for your entire life?
- 45:45Well, the recommendation is you never take it more than eight times in any one month.
- 45:51Is it going to be detrimental when you stop?
- 45:55No, you just stop getting that signal of, so to speak, arousal.
- 46:03People are flying to
- 46:05Mexico, Panama, Colombia, and Costa Rica for treatments they can easily get in the US or Europe as well.
- 46:12So are they accessing tomorrow's medicine or sometimes just escaping today's safety standards?
- 46:21What's going on with these trips?
- 46:24Well, I think it's a great marketing ploy as much as anything.
- 46:28Everybody remembers, oh, my God, I saw Mel Gibson on, you know, this great interview and his dad.
- 46:33And he went to Costa Rica or Panama or whatever it is.
- 46:36And it's a really small industry by regenerative medicine, stem cell and stuff.
- 46:40So I know most of these guys.
- 46:42There's no difference in product.
- 46:44You know, you'll go to Costa Rica, I think they're charging now $28,000 for a full therapy.
- 46:50And mostly it's a great dog and pony show.
- 46:53Is it inferior product?
- 46:55No.
- 46:56No, it's a good product.
- 46:57But you could get that product probably where you live if you look a little bit.
- 47:02It doesn't make it any better because it's in, you know, Panama or Costa Rica.
- 47:08So I want your thoughts on these two billionaires.
- 47:12One of them is Tony Robbins, who he speaks about his shoulder getting injured in a snowboarding accident.
- 47:19And then you have Dana White, the president of the UFC, also injuring his shoulder, getting stem cells.
- 47:27But I don't think it was in the States.
- 47:29Maybe they flew to New Mexico.
- 47:31Can that be correct?
- 47:32Correct.
- 47:34I knew exactly where he flew.
- 47:36And I won't say a whole lot more than that.
- 47:39But they've been public about it.
- 47:40They've been public about it.
- 47:42It was in Los Angeles, California.
- 47:44He had the first treatment in Los Angeles.
- 47:47Yeah.
- 47:48I was there.
- 47:50You were there.
- 47:52Can you share anything about it?
- 47:56Yeah, I mean, he had a shoulder problem and injected his shoulder and then did an IV therapy of the stem cells.
- 48:05And I know he followed up.
- 48:08I was not there on the second follow-up, but I was there on the primary.
- 48:11And I spoke to him a couple times, and he said he just had tremendous relief from the utilization of the regenerative product.
- 48:22And being in Los Angeles and working with some doctors,
- 48:26I've been involved with a lot of celebrities who have used it for different things, different types of whether it was black mold for a singer, bad knees for an actor, or bad back for actors and shoulders.
- 48:44So we treated a lot of them.
- 48:48Of course, you keep it private to the level that we need to.
- 48:52But Sandein was so public about it.
- 48:55He was super public about it, yeah.
- 48:57He was raving about it.
- 48:59And he did very well.
- 49:01Yeah.
- 49:03He writes about it in the book.
- 49:04And the fascinating thing is he...
- 49:07He went to four doctors and all of them said, you need surgery.
- 49:13And he just refused to accept that.
- 49:18Working in the field of orthopedics before I got out and really went into the regenerative medicine, there was like a 40% failure rate in shoulder surgeries.
- 49:29Yeah.
- 49:30That's just too high.
- 49:31That's too high, yeah.
- 49:33Yeah.
- 49:34And the recovery time was also insane.
- 49:36Oh, insane.
- 49:38And the pain is horrific.
- 49:42I wouldn't personally.
- 49:44That's my, you know...
- 49:46My thoughts, I wouldn't do it.
- 49:48We work out a lot, and I get, you know, sore and achy, and the joints hurt, and I kind of have to modify some things in order to make, you know, to continue.
- 49:57But surgery is just not my gig.
- 49:59I wouldn't do it, especially with the advent of regenerative medicine.
- 50:02Mm-hmm.
- 50:06diabetes, Parkinson's, multiple sclerosis, do you think we will ever come to a point where we can treat them completely?
- 50:18I think as long as
- 50:22They'll take the gloves off and let the scientists actually do their work.
- 50:26Yeah.
- 50:28Diabetes, physically, will we ever be able to replace those beta cells of Langerhans within the pancreas in order to create insulin?
- 50:38No.
- 50:38Maybe the mu cell is the answer there.
- 50:43MS is primarily an autoimmune problem where the immune regulation is screwed up in our body.
- 50:50There's a lot of progress on that, but I think you're going to have to catch it really early to stop it in the beginning versus trying to reverse it.
- 51:01Parkinson's and Alzheimer's and these progressive diseases are
- 51:07are very difficult, but there's also an immune and inflammatory component associated with it.
- 51:14So yeah, I think there's great hope for the future for all of those things.
- 51:19And how do you distinguish like true generation from reduced inflammation or natural recovery, placebo or wishful thinking?
- 51:30So there have been studies on knee joints, which is probably the most comprehensive.
- 51:37And it shows that there was one study that they did almost 500, I think it was 498 patients, that they did a series of stem cell injections on them.
- 51:47And they were all approved and scheduled to have knee replacement surgery.
- 51:51And one year later, only 12% of them had had the surgery.
- 51:55They did MRI and CT to check the actual thickness of the meniscus and the cartilage.
- 52:05And they saw we're able to measure measurable gains in those things.
- 52:10But here's where it comes down to the reality.
- 52:14If I'm no longer in pain because it worked,
- 52:18Do I care what the x-ray looks like?
- 52:21You know, the first thing we learned in radiology was you don't treat the x-ray, you treat the patient.
- 52:28I can't tell you how many times I saw x-rays that I was just aghast.
- 52:33And I'd ask, are you having pain here?
- 52:36No.
- 52:39I'm not going to touch you.
- 52:40Because you don't treat the x-ray.
- 52:43So it comes down.
- 52:44Did bone regenerate?
- 52:47That's not the question I want to know.
- 52:48How is your pain?
- 52:50I'm out of pain.
- 52:51I'm doing everything I want to do and I'm happy that I don't really care.
- 52:56But as a matter of fact, I wouldn't want to take the x-ray because I don't want that negative perception going on to that patient.
- 53:03Is there something we haven't touched upon that you would love to share or talk about?
- 53:09I think.
- 53:11The potential for exosomes is far greater than is really out there.
- 53:20They are the workhorse for the stem cell.
- 53:23They are the worker bee.
- 53:27Because you can make such huge volumes of them with very few stem cells, the cost is significantly reduced, probably $1.
- 53:3910 to 15% of what a stem cell infusion costs.
- 53:43The difference being you may have to have two or three therapies because they're very short-lived.
- 53:47They don't last that long.
- 53:49A stem cell itself, nobody really knows how long they live inside the body.
- 53:55But when a stem cell goes into your body, it's not from you, say the stem cell that's not from your own bone marrow or something.
- 54:03It's in a foreign environment.
- 54:05And when it's in that foreign environment, the natural reaction of that stem cell is to secrete as many components as it can to balance the environment around him.
- 54:16So what is it secreting exactly?
- 54:18Exosomes.
- 54:20So when they say, well, stem cell therapies aren't that good because the cells actually get caught in your lungs, it's actually a good thing.
- 54:27when it hits that alveoli.
- 54:27Because when it gets there and that cell becomes under stress, it puts out these massive amount of exosomes, worker bees, who then go into your bloodstream, whether it's to your brain or to the rest of your body, and they work.
- 54:40And that's why I think exosomes are kind of an unsung hero at this point because they have very widespread.
- 54:48They can do everything that the stem cell can do,
- 54:53And I think the exciting thing that's going to be coming is what are the exosome from a muse cell look like?
- 55:02And what could be their potential?
- 55:03So I love exosomes from stem cells, but I think muse cell derived exosomes have the potential really to move on beyond that.
- 55:13And I have one last question.
- 55:17What part of the future do you think we're massively underestimating?
- 55:25I think the potential for humanity working with AI together, instead of this fear-mongering about how AI is going to take everything over and destroy the world, I think how we can utilize humanity and AI at the same time.
- 55:43Because people really need to understand that without human touch,
- 55:50without that provider sitting across the chair from you, and even though he sees your blood work, but he looks at you and talks to you and understands nuance, I think when that gap is closed and we utilize AI technology to make personalized medicines and personalized therapies, and don't worry about the physician not being part of it because none of it would happen without the physician.
- 56:17None of this happens without personal touch.
- 56:21I think that's where we're going to make the biggest advancements.
- 56:26And it's been really fun to talk with you.
- 56:29And I've learned a lot.
- 56:31I'm a curious guy because there's always something new out there.
- 56:35I try to stay on top of things because health without wealth, what do we have?
- 56:42Like health is the number one wealth.
- 56:45Right.
- 56:46I agree.
- 56:47I've enjoyed it.
- 56:48It's stimulated my brain to think of things I haven't thought of in a while.
- 56:51That's awesome.
- 56:52Where can people get in contact with you?
- 56:55Do you have a clinic or?
- 56:59I don't.
- 57:01My wife is a cosmetic chemist and we're in Los Angeles.
- 57:05And so we create peptide enhanced cosmetic products.
- 57:10at kairosbeautylab.com.
- 57:12That's Kairos, K-A-I-R-O-S, beautylab.com.
- 57:17We do educational programs, private labeling, and we create peptide enhanced cosmetic products for the similar reasons why people take them injectable, but it's all for beauty and it's all topical.
- 57:33Just cause I'm curious, why Cairo?
- 57:36Why the name Cairo?
- 57:38So, chronos is the Latin word for watch.
- 57:45Kairos is the Greek word.
- 57:47And biblically, kairos is used in the Bible saying it is in kairos time or in God's time.
- 57:54So, that's why we utilize the word kairos.
- 57:57All right.
- 57:58I'm half Egyptian.
- 57:59I didn't know that Cairo was the Greek word for time.
- 58:04Did I get that correct?
- 58:05Yeah.
- 58:06And chrono, right?
- 58:07Chrono is your watch.
- 58:08Chrono for?
- 58:09Is Latin.
- 58:09All right.
- 58:11And Cairo says the Greek version.
- 58:13Yeah.
- 58:15Okay.
- 58:16I learned a ton of shit right now.
- 58:22That's awesome.
- 58:22I enjoyed it.
- 58:23Dr. Alan Gavick.
- 58:24I'll put all the links in the show notes.
- 58:26Check it out.
- 58:28And it's been phenomenal.
- 58:29Thank you so much for joining the show and being so generous with your time and your knowledge.
- 58:34Thank you.
- 58:35Well, I hope to see you soon.